Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

(1) The number of shares of common stock to be outstanding after this offering is based on 155.1 million shares of common stock outstanding as of May 6, 2018 and excludes 41.4 million shares issuable upon the exercise of stock options outstanding at March 31, 2018 and shares issuable upon the conversion of amounts outstanding under a convertible loan held by the Company’s Chief Executive Officer, which included approximately 4.1 million shares as of March 31, 2018.



(2) Except as otherwise indicated, all information in the prospectus supplement, including the number of shares of common stock outstanding immediately after this offering, assumes no exercise of the commitment warrants and that the additional securities consist of 13.2 million shares of common stock at a price of $0.38 per share.

Shares of common stock to be outstanding after this offering
176.2 million shares of our common stock(1)(2)